Results 51 to 60 of about 1,308,546 (203)
ABSTRACT In recent years the addition of the oral BCL2 inhibitor venetoclax to hypomethylating agents (HMAs) has emerged as the standard‐of‐care for patients with acute myeloid leukemia (AML) who are not fit for intensive chemotherapy, significantly improving survival and quality‐of‐life.
Mariarita Sciumè +9 more
wiley +1 more source
Invasive Pulmonary Aspergillosis-mimicking Tuberculosis [PDF]
Pulmonary tuberculosis is occasionally confused with invasive pulmonary aspergillosis (IPA) in transplant recipients, since clinical suspicion and early diagnosis of pulmonary tuberculosis and IPA rely heavily on imaging modes such as computed tomography (CT).
Sung-Han, Kim +9 more
openaire +2 more sources
Mixed Invasive Fungal Pneumonia Caused by Aspergillus, Candida, Mucor in an Immunocompromised Host
We report a case of mixed invasive fungal pneumonia caused by Aspergillus, Candida and Mucor species in an immunocompromised host, highlighting the diagnostic and therapeutic implications of concurrent opportunistic fungal infections. ABSTRACT Invasive fungal pneumonia (IFP) is a life‐threatening complication in immunocompromised patients, particularly
Taeyun Kim +6 more
wiley +1 more source
Successful surgical management of invasive aspergillosis of the pulmonary arteries
We describe an 11-year-old girl with severe obstruction of the main pulmonary arteries caused by invasive aspergillosis and managed with combined pulmonary endarterectomy and antimycotic ...
R. Dore +6 more
core +1 more source
COVID-19 associated pulmonary aspergillosis in ICU patients: Report of five cases from Argentina
Invasive pulmonary aspergillosis is a complication in critically ill patients with acute respiratory distress syndrome, especially those with severe coronavirus disease-associated pneumonia.
María Fernanda Benedetti +8 more
doaj +1 more source
Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone +9 more
wiley +1 more source
ABSTRACT Rhino‐orbital mucormycosis can present aggressively in immunocompetent adults, often with atypical initial symptoms that lead to misdiagnosis and dangerous delays. A high index of suspicion is paramount when facing a rapidly progressive orbital infection unresponsive to conventional therapy.
Seyed Mohammad Mousavi +5 more
wiley +1 more source
Influenza-associated pulmonary aspergillosis in a patient on ECMO
Invasive pulmonary aspsergillosis (IPA) is a well-known disease typically affecting severely immunocompromised patients. Recently, IPA has been described in a new group of patients such as those infected with influenza.
Khaled Alobaid +2 more
doaj +1 more source
Airborne pathogens like Aspergillus bring the lungs in the frontline for defense. Pulmonary diseases caused by Aspergillus species are broadly classified as aspergilloma, chronic necrotizing pulmonary aspergillosis, invasive pulmonary aspergillosis (IPA),
Mayuri Mahajan +3 more
doaj +1 more source
Interpretable Machine Learning Model for Fungal Infection Prediction: A Real‐World Study
Our study successfully developed and validated a machine learning model based on large‐scale electronic health record data to predict the risk of fungal infections in hospitalized patients. Through a Streamlit‐powered web platform, the model was seamlessly embedded into clinical workflows, completing the full pipeline from model construction to real ...
Jinru Yang +5 more
wiley +1 more source

